Table 2.

Comparison of plasmatic concentrations on chip biomarkers between studied subgroups.

Laboratory parameters	All patients(n=89)	Favorable outcome subgroup (n 1=67)	Unfavorable outcome subgroup (n 2=22)	P *
CRP (mg/L)	6.3±3.23	6.0±3.22	7.4±3.09	0.073
hsCRP (mg/L)	5.0 (3.00–12.00)	5.0 (2.00–10.00)	9.0 (4.00–14.00)	0.047
NGAL (ng/mL)	742.4±255.91	729.7±256.33	781.7±256.60	0.417
NSE (ng/mL)	15.9±8.81	17.2±7.28	12.3±4.89	0.004
sTNFR1(ng/mL)	1.1 (0.90–1.31)	1.1 (0.83–1.12)	1.5 (1.15–1.52)	<0.001
D Dimers (ng/mL)	185.1 (185.06–245.06)	185.1 (166.33–203.61)	245.1 (230.09–331.20)	<0.001

^*Estimated significance level obtained from Student t-test, Mann-Whitney or Chi-square tests.